IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 225 filers reported holding IVERIC BIO INC in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,997,375 | +60.0% | 186,706 | +34.0% | 1.18% | +57.3% |
| Q3 2022 | $2,499,000 | +165.9% | 139,315 | +42.5% | 0.75% | +185.6% |
| Q2 2022 | $940,000 | -23.7% | 97,745 | +33.5% | 0.26% | -4.4% |
| Q1 2022 | $1,232,000 | +0.7% | 73,196 | 0.0% | 0.28% | +10.4% |
| Q4 2021 | $1,224,000 | -31.6% | 73,196 | -33.6% | 0.25% | -4.6% |
| Q3 2021 | $1,790,000 | +9.7% | 110,231 | -57.4% | 0.26% | +11.1% |
| Q2 2021 | $1,632,000 | +119.9% | 258,580 | +115.3% | 0.24% | +109.8% |
| Q1 2021 | $742,000 | +19.7% | 120,075 | +33.9% | 0.11% | +3.7% |
| Q4 2020 | $620,000 | – | 89,665 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
| COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
| Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
| Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
| Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
| Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
| ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
| Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
| Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
| Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |